Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
26 hedge funds and large institutions have $2.02M invested in Celgene Corporation Contingent Value Rights in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
24% more capital invested
Capital invested by funds: $1.62M → $2.02M (+$397K)
4% more funds holding
Funds holding: 25 → 26 (+1)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UAS
United Asset Strategies
Garden City,
New York
|
+$145K |
| 2 |
AC
Ascend Capital
Orinda,
California
|
+$65.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$20.4K |
| 4 |
DC
Davenport & Co
Richmond,
Virginia
|
+$2.58K |
| 5 |
MSTVIM
Messner & Smith Theme Value Investment Management
San Diego,
California
|
+$1.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$42K |
| 2 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$42K |
| 3 |
MC
Muhlenkamp & Co
Wexford,
Pennsylvania
|
-$18K |
| 4 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$5.63K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.73K |
CELGZ Hedge Fund Activity: Q2 2016 in Review
26 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q2 2016, worth a combined $2.02M — up 24% from $1.62M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CELGZ positions and 3 closed out — a net gain of 1 holder — while 3 added to existing stakes and 5 trimmed.
The largest buyer was United Asset Strategies, opening a new position worth an estimated $145K. The largest seller was Citadel Advisors, exiting entirely with an estimated $42K sold.
- 26 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q2 2016, up from 25 in Q1 2016.
- Funds reported $2.02M of Celgene Corporation Contingent Value Rights stock for Q2 2016, up 24% quarter-over-quarter.
- 4 funds opened new Celgene Corporation Contingent Value Rights positions in Q2 2016 and 3 closed out, a net change of +1 holder.
- The largest Celgene Corporation Contingent Value Rights buyer in Q2 2016 was United Asset Strategies, an estimated $145K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q2 2016 was Citadel Advisors, an estimated $42K sold.
Based on aggregated 13F filings for Q2 2016.